Treatment with the Immunomodulator AIC649 in Combination with Entecavir Produces Antiviral Efficacy in the Woodchuck Model of Chronic Hepatitis B

被引:8
作者
Korolowicz, Kyle E. [1 ]
Suresh, Manasa [1 ]
Li, Bin [1 ]
Huang, Xu [1 ]
Yon, Changsuek [1 ]
Leng, Xuebing [1 ]
Kallakury, Bhaskar V. [2 ]
Tucker, Robin D. [3 ]
Menne, Stephan [1 ]
机构
[1] Georgetown Univ, Med Ctr, Dept Microbiol & Immunol, Washington, DC 20057 USA
[2] Georgetown Univ, Dept Pathol, Med Ctr, Washington, DC 20057 USA
[3] Georgetown Univ, Div Comparat Med, Med Ctr, Washington, DC 20057 USA
来源
VIRUSES-BASEL | 2021年 / 13卷 / 04期
基金
美国国家卫生研究院;
关键词
parapoxvirus; TLR9; entecavir; woodchuck; chronic hepatitis B; antiviral efficacy; immune response; PLASMACYTOID DENDRITIC CELLS; TOLL-LIKE RECEPTORS; OVIS ORF-VIRUS; HEPATOCELLULAR-CARCINOMA; ALPHA/BETA INTERFERON; NUCLEOTIDE-SEQUENCE; IMMUNE-RESPONSES; SURFACE-ANTIGEN; ANIMAL-MODEL; THERAPY;
D O I
10.3390/v13040648
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
As current interventions for chronic hepatitis B (CHB) rarely induce cure, more effective drugs are needed. Short-term treatment of woodchucks with the novel immunomodulator AIC649, a parapoxvirus-based stimulator of toll-like receptor 9 dependent and independent pathways, has been shown to reduce viral DNA and surface antigen via a unique, biphasic response pattern. The present study evaluated long-term AIC649 treatment in combination with Entecavir for potency and safety in woodchucks. AIC649 monotreatment induced modest reductions in serum viral DNA and surface and e antigens that were associated with the same biphasic response pattern previously observed. Entecavir monotreatment reduced transiently viremia but not antigenemia, while AIC649/Entecavir combination treatment mediated superior viral control. Undetectability of viral antigens and elicitation of antibodies in AIC649/Entecavir-treated woodchucks correlated with the expression of interferons and suppression of viral replication in liver. Combination treatment was well tolerated, and liver enzyme elevations were minor and transient. It was concluded that the AIC649-mediated effects were most likely based on an improvement and/or reconstitution of antiviral immune responses that are typically deficient in CHB. As a combination partner to Entecavir, the antiviral efficacy of AIC649 was markedly enhanced. This preclinical study supports future evaluation of AIC649 for treatment of human CHB.
引用
收藏
页数:24
相关论文
共 90 条
[1]   Safety and efficacy of vesatolimod (GS-9620) in patients with chronic hepatitis B who are not currently on antiviral treatment [J].
Agarwal, K. ;
Ahn, S. H. ;
Elkhashab, M. ;
Lau, A. H. ;
Gaggar, A. ;
Bulusu, A. ;
Tian, X. ;
Cathcart, A. L. ;
Woo, J. ;
Subramanian, G. M. ;
Andreone, P. ;
Kim, H. J. ;
Chuang, W. L. ;
Nguyen, M. H. .
JOURNAL OF VIRAL HEPATITIS, 2018, 25 (11) :1331-1340
[2]  
Agarwal K, 2020, J HEPATOL, V73, pS125
[3]   The Genome Sequence of the Eastern Woodchuck (Marmota monax) - A Preclinical Animal Model for Chronic Hepatitis B [J].
Alioto, Tyler S. ;
Cruz, Fernando ;
Gomez-Garrido, Jessica ;
Triyatni, Miriam ;
Gut, Marta ;
Frias, Leonor ;
Esteve-Codina, Anna ;
Menne, Stephan ;
Kiialainen, Anna ;
Kumpesa, Nadine ;
Birzele, Fabian ;
Schmucki, Roland ;
Gut, Ivo G. ;
Spleiss, Olivia .
G3-GENES GENOMES GENETICS, 2019, 9 (12) :3943-3952
[4]  
Bellezza C. A., 2002, Laboratory animal medicine, P309, DOI 10.1016/B978-012263951-7/50011-9
[5]   Liver-directed gene therapy of chronic hepadnavirus infection using interferon alpha tethered to apolipoprotein A-I [J].
Berraondo, Pedro ;
Di Scala, Marianna ;
Korolowicz, Kyle ;
Thampi, Linta M. ;
Otano, Itziar ;
Suarez, Lester ;
Fioravanti, Jessica ;
Aranda, Fernando ;
Ardaiz, Nuria ;
Yang, Junming ;
Kallakury, Bhaskar V. ;
Tucker, Robin D. ;
Vasquez, Marcos ;
Menne, Stephan ;
Prieto, Jesus ;
Gonzalez-Aseguinolaza, Gloria .
JOURNAL OF HEPATOLOGY, 2015, 63 (02) :329-336
[6]   Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection [J].
Bertoletti, Antonio ;
Ferrari, Carlo .
GUT, 2012, 61 (12) :1754-1764
[7]   TLR7 Agonist Increases Responses of Hepatitis B Virus-Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues [J].
Boni, Carolina ;
Vecchi, Andrea ;
Rossi, Marzia ;
Laccabue, Diletta ;
Giuberti, Tiziana ;
Alfieri, Arianna ;
Lampertico, Pietro ;
Grossi, Glenda ;
Facchetti, Floriana ;
Brunetto, Maurizia R. ;
Coco, Barbara ;
Cavallone, Daniela ;
Mangia, Alessandra ;
Santoro, Rosanna ;
Piazzolla, Valeria ;
Lau, Audrey ;
Gaggar, Anuj ;
Subramanian, G. Mani ;
Ferrari, Carlo .
GASTROENTEROLOGY, 2018, 154 (06) :1764-+
[8]   Restored Function of HBV-Specific T Cells After Long-term Effective Therapy With Nucleos(t)ide Analogues [J].
Boni, Carolina ;
Laccabue, Diletta ;
Lampertico, Pietro ;
Giuberti, Tiziana ;
Vigano, Mauro ;
Schivazappa, Simona ;
Alfieri, Arianna ;
Pesci, Marco ;
Gaeta, Giovanni B. ;
Brancaccio, Giuseppina ;
Colombo, Massimo ;
Missale, Gabriele ;
Ferrari, Carlo .
GASTROENTEROLOGY, 2012, 143 (04) :963-+
[9]  
Burton AR, 2018, J CLIN INVEST, V128, P4588, DOI [10.1172/JCI121960, 10.1172/jci121960]
[10]   Treatment of chronic hepatitis B infection-2017 [J].
Chen, Guo-Feng ;
Wang, Cheng ;
Lau, George .
LIVER INTERNATIONAL, 2017, 37 :59-66